The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, “Virafin” for treating moderate COVID-19 infection in adults.
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, “Virafin” for treating moderate COVID-19 infection in adults.